Uppsala Reports editor
@UMCGlobalSafety
Covering the world of pharmacovigilance
Clinical trials are the “gold standard” of evidence-based medicine – the best way we have to test whether a drug is safe and effective before it enters the market. But if trial data is poorly reported or – even worse – left unpublished, how are we supposed to determine the true value of a medical treatment?
Peter Doshi, associate editor at The BMJ and founder of the Restoring Invisible and Abandoned Trials (RIAT) Support Center, has made it his mission to fix the problem and improve data transparency for good.
Subscribe by visiting the Drug Safety Matters website or listen in right here:
Learn more
To find out a lot more about Peter Doshi and his work, be sure to visit the RIAT Support Center here.
Peter Doshi on Drug Safety Matters. Photo: UMC
